The papain superfamily member bleomycin hydrolase (Blmh) is a neutral cysteine protease with structural similarity to a 20S proteasome. Bleomycin (BLM), a clinically used glycopeptide anticancer agent, is deaminated in vitro by Blmh. We used gene targeting to generate mice that lack Blmh and demonstrated that Blmh is the sole enzyme required for BLM deamination. Although some Blmh null mice were viable and reproduced, only about 65% of the expected number survived the neonatal period, revealing an important role for Blmh in neonatal survival. Mice lacking Blmh exhibited variably penetrant tail dermatitis that resembled rodent ringtail. The histopathology of the tail dermatitis was similar to skin lesions in humans with pellagra, necrolytic migratory erythema, and acrodermatitis enteropathica. Compared with controls, Blmh null mice were more sensitive to acute BLM lethality and developed pulmonary fibrosis more readily following BLM treatment. Thus, we have established that Blmh is an essential protectant against BLM-induced death and has an important role in neonatal survival and in maintaining epidermal integrity.
Cysteine proteases are a diverse group of important enzymes that include the caspase, calpain, and papain families. Bleomycin hydrolase (Blmh) is a neutral cysteine protease assigned to the papain superfamily based on the conserved amino acid motif surrounding the catalytic cysteine (1) . Blmh is expressed in bacteria, yeast, birds, reptiles, and mammals (2-7) with little apparent tissue specificity (7, 8) . This ubiquitous distribution suggests an important and as yet undetermined biological role.
The trivial name of Blmh reflects the ability of the enzyme to deaminate and consequently inactivate bleomycin (BLM), a clinically used glycopeptide anticancer agent. Unlike BLM, the metabolite desamido-BLM cleaves DNA poorly and lacks cytotoxicity (9, 10) . Yeast strains expressing high levels of Blmh are more resistant to BLM compared with wild-type strains (3) . Yeast mutant strains that lack functional Blmh respond to BLM like wild-type cells, suggesting that redundant function(s) may complement the mutated Blmh gene (3) . Whether redundant cellular activities inactivate BLM or whether orthologues can regulate cell resistance to BLM has not been established in mammals. In BLM-resistant human tumor-cell subclones, 2-to 3-fold more BLM deamidating activity has been observed (11) , and treatment with transepoxysuccinyl-L-leucylamido-(4-guanidino)butane (E-64), a cysteine proteinase specific inhibitor, sensitizes tumors to BLM in vitro (12) and in vivo (13) . Collectively, these data suggest that mammalian Blmh may be an important participant in cellular metabolism of and resistance to BLM.
BLM-induced pulmonary fibrosis has been a significant deterrent to the liberal use of this anticancer agent (14) . Low BLM metabolizing activity has been hypothesized to be the biochemical basis for BLM-induced pulmonary toxicity (10) . The factors responsible for other untoward side effects seen in patients treated with BLM, including s.c. toxicity (15) and vascular lesions (16) such as Raynaud's phenomenon (17) , are unknown. Recently, we (18) and others (19) reported the genomic organization and chromosomal location (17q11.2) of human BLMH, which is a single-copy gene encoding the 455 amino acid Blmh protein. Although the genetic locus of murine Blmh is unknown, the region predicted from the human location is one of several mapped for sensitivity to BLMinduced toxicity (20) . The development of a mouse model lacking Blmh will help elucidate the natural physiologic function of this highly conserved and ubiquitous cysteine protease and its role in protecting mammals from the toxic actions of BLM.
MATERIALS AND METHODS
Production and Evaluation of Knockout Mice. Strain 129͞ Ola mouse genomic Blmh DNA was isolated from a P1 3 Hit Mouse ES Library (Genome Systems, St. Louis) by screening with PCR primers that corresponded to nucleotides 263-284 and 393-371 of rabbit Blmh cDNA (1) . A replacement-type targeting vector (21) was constructed by subcloning genomic DNA (Fig. 1A , hatched line) to flank a neomycin phosphotransferase (neo) cassette (targeting vector not shown). R1 embryonic stem (ES) cells (22) were transfected by electroporation with the linearized targeting vector and individual G418͞ganciclovir-resistant clones were screened for homologous recombination by Southern blot analysis. Ganciclovir was used for negative selection against random vector insertion because the targeting vector contained a thymidine kinase gene located outside of the homologous recombination region. In addition, the targeted allele was differentiated from the wild-type allele by three-primer PCR analysis. The forward primer (p1) for amplification of both the wild-type and targeted allele was 5Ј-CACTGTAGCTGTACTCACAC-3Ј. The reverse primers that differentiated the wild-type and targeted allele were 5Ј-GCGACAGAGTACCATGTAGG-3Ј (p2) and 5Ј-ATTTGTCACGTCCTGCACGACG-3Ј (p3), respectively.
Two independently targeted ES cell clones, Bh#127 and Bh#G8 (carrying the targeted mutations Blmh tm1Geh and Blmh tm2Geh , respectively), generated founder chimeric mice that transmitted the targeted allele through the germ line following mating to either C57BL͞6J (The Jackson Laboratory) or 129͞SvEvTac (Taconic Farms) females. Heterozygous
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked ''advertisement'' in accordance with 18 U.S.C. §1734 solely to indicate this fact. offspring were intercrossed to produce Blmh wild-type (Bhϩ͞ ϩ), heterozygous (Bhϩ͞Ϫ), and null (BhϪ͞Ϫ) mice. Because R1 ES cells are a hybrid of strains 129͞Sv and 129͞SvJ, the genetic background of the mice used in this study was either C57BL͞6J ϫ 129͞Sv͞SvJ (B6, 129) or 129Sv͞SvJ ϫ 129͞ SvEvTac (129). Unless otherwise specified, the results presented were generated from mice carrying the Blmh tm1Geh targeted allele. 129-Blmh tm1Geh breeding pairs and their litters were fed Prolab Isopro breeder chow (no. 5028, containing 9% fat, 30 international units͞g vitamin A; T. R. Last, Pittsburgh). All other mice were fed Prolab Isopro chow (no. 3000, containing 6% fat, 19 international units͞g vitamin A, T. R. Last). Weight of mice at weaning was evaluated using a Student's t test.
Northern Blot and Blmh Enzymatic Activity Assays. Total RNA for Northern blot analysis was isolated from embryonic day 16-18 whole embryos using TRIzol reagent (Life Technologies). Blmh mRNA was detected with probe A (see Fig.  1 A, b) . RNA loading (Ϸ15 g per lane) and integrity was monitored with a human ␤-actin cDNA probe (CLONTECH). Blmh enzymatic activity was assayed in postmicrosomal supernatant fractions by resolving bleomycin A 2 (BLM A 2 ) from the desamido-BLM A 2 metabolite by HPLC as previously described (23) .
BLM Treatment and Hydroxyproline Assay. Weightmatched female 10-to 12-week-old mice from both genetic backgrounds were used. Mice received BLM (10-100 mg͞kg; Sigma) or vehicle (saline) as a constant s.c. infusion delivered by mini-osmotic pump (model 2001, Alza) as described (24) . Six weeks after initiation of BLM treatment, mice were deeply anesthetized by methoxyflurane (Pitman-Moore, Mundelein, IN) and the thoracic cavity was exposed. The right lung was removed and its hydroxyproline content was determined as described (10) . Data were analyzed by Student's t test.
Exposure of Mice to High and Low Relative Humidity. Adult BhϪ͞Ϫ and Bhϩ͞ϩ littermates lacking tail dermatitis were placed in cages (n Յ 4) and fed chow and water ad lib. The cages were placed in two sealed clear Plexiglas (Commercial Plastics and Supply, Pittsburgh) chambers (60 ϫ 82 ϫ 39 cm) with continuous air circulation of 10 liters͞min. One chamber was maintained at high humidity by circulating air that was percolated through reservoirs containing sterile deionized H 2 O. A second chamber was maintained at low humidity by inclusion of Drierite (Fisher Scientific) in the chamber. Humidity and temperature were recorded daily with a dual hygrometer͞thermometer (VWR Scientific).
Histology. At the time of necropsy, tail biopsies were submerged in 4% paraformaldehyde in 0.1 M sodium phosphate (pH 7.2) overnight at 4°C. Fixed tails were decalcified in 10% nitric acid for 6 hr at room temperature, and 2-to 3-mm-thick pieces were paraffin embedded, sectioned at 6 m, and stained with hematoxylin and eosin. Other necropsy tissue was treated as above without decalcification.
RESULTS
Production and Molecular Characterization of Mice. Homologous recombination in murine ES cells was used to abrogate Blmh gene expression (Fig. 1 A) . The targeting vector was designed to replace exon 3 and 3.4 kb of flanking DNA with a neo gene. Deletion of exon 3 removed the critically important catalytic cysteine. Of 475 G418͞ganciclovir-resistant ES cell clones analyzed, six had restriction fragment length polymorphisms indicative of gene targeting at the Blmh locus, and two (Bh#127 and Bh#G8 containing Blmh tm1Geh and Blmh tm2Geh targeted alleles, respectively) were chosen for further analysis. Probe A (see Fig. 1 A, b) hybridized to the 8.5-kb BglII fragment from the wild-type allele found in R1 parental ES cells and to a 6.0-kb BglII fragment from the Blmh tm1Geh and Blmh tm2Geh targeted alleles (Fig. 1B, a) . Interestingly, an additional 6.5-kb band hybridized to probe A from the Blmh tm2Geh allele (Fig. 1B, a) . After extensive Southern blot analysis we have determined that the targeting event in Blmh tm2Geh resulted in duplication of both the homologous recombination region of the targeting vector and a small fragment of DNA (Ϸ1.5 kb) surrounding exon 2. We have also detected two copies of the targeting construct integrated at the Blmh locus in Blmh tm1Geh . Importantly, following extensive characterization of the targeted alleles with several restriction enzyme͞probe combinations, we have concluded that there are no alterations outside of the region of homologous recombination (data not shown). Both ES cell clones described above produced chimeric founder mice that passed the targeted allele through the germ line. Three-primer PCR analysis demonstrated that both targeted alleles lacked the 3.4-kb Blmh genomic region, which contains exon 3 and hybridizes to primer p2 (see Fig. 1 A) . Blmh null alleles, therefore, lack the Ϸ650-bp wild-type PCR amplicon that was synthesized between primers p1 and p2 (Fig. 1B, b) .
Importantly, we established in BhϪ͞Ϫ mice that the Blmh tm1Geh and Blmh tm2Geh targeted alleles were nonfunctional (i.e., true null alleles) by absence of wild-type Blmh mRNA (Fig. 1C) , lack of Blmh protein (by Western blot analysis, data not shown), and failure of tissue homogenates to metabolize BLM (Fig. 1D) . Pulmonary homogenates from Bhϩ͞ϩ and BhϪ͞Ϫ mice were tested for their ability to metabolize BLM A 2 to its metabolite desamido-BLM A 2 . BLM A 2 and desamido-BLM A 2 were resolved by reverse-phase HPLC and clearly detected by absorbance at 290 nm (Fig. 1D) ; compare HPLC traces from reactions with only substrate (a), only homogenate (b), or wild-type homogenate incubated with substrate (c). Pulmonary homogenates from Bhϩ͞ϩ mice metabolized Ͼ30% of the parent compound to desamido-BLM A 2 (Fig. 1D, c) . The cysteine protease inhibitor E-64 prevented the metabolism of BLM A 2 (Fig. 1D, d) , suggesting that production of desamido-BLM A 2 by Bhϩ͞ϩ homogenate was due to cysteine protease enzymatic activities. BhϪ͞Ϫ lung and liver (data not shown) homogenates, importantly, did not metabolize BLM A 2 , even after 12 hr at 37°C (Fig. 1D, e) . Significantly, no alternate BLM metabolites appeared after long exposure to BhϪ͞Ϫ lung homogenates (Fig. 1D, e) . This finding demonstrates that only Blmh is capable of deaminating BLM in mammalian cells and that Blmh is a single-copy gene in mice. We conclude, therefore, that the strategy employed for targeted disruption of the Blmh gene resulted in a verifiable Blmh null allele and that cytosolic deamination of BLM cannot be replaced by a redundant mechanism in BhϪ͞Ϫ mammalian cells.
Neonatal Lethality, Abnormal Epidermis of the Tail, and Reduced Body Weight. Approximately 64% (139) of the expected number (218) of null animals (from both backgrounds) survived to weaning ( Table 1 ). The distribution of genotypes was significantly different from the expected 1:2:1 Medelian distribution. A similar trend was observed for BhϪ͞Ϫ mice having the Blmh tm2Geh allele, although the number of mice available in our secondary mouse colony limited the power of our statistical analysis (data not shown). To assess whether or not the BhϪ͞Ϫ deaths occurred in utero, we genotyped DNA derived from whole embryos (embryonic day 14-18). All embryos appeared viable and no embryo reabsorptions were observed in three litters (n ϭ 30 embryos). The genotypes did not differ significantly from a 1:2:1 Mendelian distribution (Table 1) . Therefore, Ϸ36% of the BhϪ͞Ϫ pups died as neonates; the cause of death has not been determined. Those BhϪ͞Ϫ mice that survived the neonatal period were healthy and fertile.
Most newborn Blmh null mice appeared normal except for unusual dermatopathy presenting initially as a mild ichthyoticlike appearance with generalized scaling and sloughing of the skin over the entire body. At about the time of expression of pigment within hair follicles (Ϸ7-10 days), the scaling resolved except on the tail. When BhϪ͞Ϫ pups were about 5-to 7-days old, annular constrictions began to appear on the tail ( Fig. 2A ) followed by swelling (dermatitis), erythmatosis, and necrosis and autoamputation of the tip. The gross tail lesions were found exclusively on BhϪ͞Ϫ mice, regardless of genetic background (Fig. 2 A) . The penetrence and the severity of the lesions were variable. Frequently, the lesions resolved by weaning. Both male and female BhϪ͞Ϫ mice were housed individually without resolution of the tail pathology (data not shown), indicating that the lesions were not caused by aggressive behavior. No lesions were observed in weanlings or adults on other areas of exposed skin (e.g., ears or feet), or on shaved backs of adults exposed to ambient laboratory light 24 hr per day (data not shown), which eliminated visible light as an etiologic agent. The gross lesions were strikingly similar to rodent ringtail, a condition first described Ͼ40 years ago (25) , which has an elusive etiology. Similar to ringtail, the tail dermatitis in BhϪ͞Ϫ mice included thickening of the epidermis (parakeratotic hyperkeratosis and acanthosis), areas of necrosis, and neutrophil infiltrate (Fig. 2 D-F) . Unlike ringtail, ballooning degeneration of the upper stratum spinosum and pallor (Fig. 2E) were observed in some BhϪ͞Ϫ tails. There was no evidence of underlying angitis or vascular thrombosis. In the most severe cases (Fig. 2F) , a thick hardened exudate or inflammatory scale-crust was present on the tail surface with full-thickness epidermal necrosis and an abundant epidermal neutrophil infiltrate. Rodent ringtail has been reported to be induced by low (Ͻ40%) relative humidity (25) . Our mice were housed in a facility that had centrally controlled (Ͼ40%) relative humidity, however, and there was no evidence of ringtail in any other mouse colony or strain within the facility. Nonetheless, we monitored the humidity directly in our mouse quarters and found that during the coldest ambient weather (roughly Ͻ10°C), the relative humidity transiently dropped as low as 25%. Therefore, we tested the hypothesis that tail lesions expressed only on BhϪ͞Ϫ mice were induced by low relative humidity. Wild-type and BhϪ͞Ϫ littermates (8-10 weeks), with no evidence of dermatitis throughout their life, were placed in chambers that received 10 liters͞min of either humidified or arid air for 20 days. The mean relative humidity in the humid and dry chambers was 80.1 Ϯ 1.2% and 20.7 Ϯ 0.6%, respectively. Only BhϪ͞Ϫ mice in the dry atmosphere developed tail dermatitis (Fig. 3) . Histologically, lowhumidity-induced tail lesions on BhϪ͞Ϫ mice had features also present in spontaneous tail lesions, namely parakeratotic hyperkeratosis (data not shown). Rodent ringtail in rats has been alleviated by changing the source of fat and vitamin A (26). Switching our 129-Blmh tm1Geh breeding colony from normal chow to high-fat breeder chow did not alter the expression, severity, or frequency of observed dermatitis, irrespective of the ambient humidity (data not shown).
A general histopathological evaluation of multiple tissues from BhϪ͞Ϫ and Bhϩ͞ϩ littermates was performed. BhϪ͞Ϫ mice replete with conspicuous tail dermatitis lacked abnormalities in other examined tissues (data not shown). BhϪ͞Ϫ mice did frequently appear smaller than their wild-type (see Fig. 2 A) or heterozygous littermates. Body weight at the time female pups were weaned (19-22 days after birth) for 129-Blmh tm1Geh litters (between 5 and 8 surviving pups) was 10.95 Ϯ 0.53 g (n ϭ 13) for Bhϩ͞ϩ mice and 9.46 Ϯ 0.74 g (n ϭ 7) for BhϪ͞Ϫ mice (P ϭ 0.05).
In Vivo Response to BLM. Adult wild-type and null mice were treated s.c. with BLM for 7 days to determine if BhϪ͞Ϫ mice were more sensitive to the drug's toxic effects. Blmh deficiency clearly sensitized mice to the toxic effects of BLM because all BhϪ͞Ϫ mice (n ϭ 8) exposed to 100 mg͞kg BLM died on day 9-10 following pump implantation (Table 2 ). In contrast, 1 of 13 Bhϩ͞ϩ mice died after being treated similarly (Table 2) . BLM-induced lethality in BhϪ͞Ϫ mice (1 of 4) was also observed after 50 mg͞kg (data not shown). The BLMresistant Bhϩ͞ϩ mice survived beyond 6 weeks post-drug delivery, which is consistent with previous reports (24) . Necropsy of two BhϪ͞Ϫ mice that received 100 mg͞kg BLM revealed evidence of lesions in bone marrow and gut. Within medullary regions of bone, there was a general loss of normal hematopoetic cellularity, especially erythroid components. The marrow appeared hypercellular, which is associated with the infiltration of large numbers of mature neutrophilic inflammatory cells. Multifocal regions of mild gastritis with associated superficial mucosal ulceration and hemorrhage were also seen, which could have been exacerbated by anorexia. We conclude that mammalian Blmh protects whole organisms from BLM.
Next, we examined the sensitivity of BhϪ͞Ϫ mice to the pulmonary fibrotic effects of BLM. The extreme sensitivity of BhϪ͞Ϫ mice to the acute toxicity of BLM, however, restricted our study to nonlethal, low doses of BLM. We found BhϪ͞Ϫ mice reproducibly had less basal hydroxyproline, a biochemical marker of collagen (27) , than Bhϩ͞ϩ mice (Fig. 4) . This may reflect a smaller lung size in the null mice. As expected, Bhϩ͞ϩ mice had similar levels of hydroxyproline after lowdose BLM treatment compared with saline (Fig. 4 ). In contrast, BhϪ͞Ϫ mice treated with 25 mg͞kg BLM reproducibly had significantly elevated hydroxyproline levels (30 Ϯ 0.13%; P Ͻ 0.05) due to collagen deposition during fibrosis. Our data were appropriately normalized to total lung, rather than wet tissue weight or total protein, as has been established by others (28, 29) . The magnitude of the hydroxyproline increase in the BhϪ͞Ϫ mice was consistent with our expectations at these normally nontoxic doses. Thus, the absence of Blmh significantly increased BLM-induced pulmonary fibrosis.
DISCUSSION
The creation of mice that specifically and completely lack detectable Blmh enzymatic activity unambiguously demonstrated a unique and nonredundant role for Blmh in BLM metabolism. Moreover, BhϪ͞Ϫ mice were hypersensitive to the deleterious effects of BLM because doses that were without effect in Bhϩ͞ϩ mice elicited either pulmonary fibrosis (25 mg͞kg) or lethality (50 or 100 mg͞kg) in BhϪ͞Ϫ mice. As a result, we have unequivocally demonstrated a role for Blmh in protecting mammalian tissue and animals from BLM-induced toxicity. Development of a mammalian model that lacks BLM deaminating activity may greatly facilitate research aimed at understanding and preventing BLMinduced pulmonary fibrosis.
BhϪ͞Ϫ mice had additional phenotypic abnormalities. Approximately 36% of BhϪ͞Ϫ mice died as neonates by an unknown mechanism. Viable BhϪ͞Ϫ neonates frequently presented with tail dermatitis that was greatly exacerbated by dry air. The gross anatomical features of the dermatitis resembled rodent ringtail, which has been observed in rats, mice, and the white-tailed hamster (25, (30) (31) (32) , and has been associated with arid conditions (25, 32) . The ringtail-like features in the BhϪ͞Ϫ mice include: sloughing skin, annular constrictions, erythmatosis, crust formation, necrosis, and autoamputation (Fig. 2) . The specific combination of histopathological changes observed in the BhϪ͞Ϫ tail, namely ballooning degeneration of the upper stratum spinosum and pallor, together with typical markers of rodent ringtail such as hyperkeratosic parakeratosis, neutrophilic infiltrate, and necrosis, have not been reported previously (26, 33) . Instead, this unique combination of histomorphological features in BhϪ͞Ϫ tail lesions was similar to descriptions of human skin lesions associated with pellagra, necrolytic migratory erythema (glucagonoma), and acrodermatitis enteropathica (34) . These human conditions result from disparate nutritional deficiencies (34) . Interestingly, fat, fatty acid, and vitamin B (except B 2 ) nutritional deficiencies have been suggested as etiologic factors in ringtail (32) . The Blmh null mice, therefore, may provide a unique model to probe the as yet unknown molecular mechanism(s) responsible for these lesions.
The Blmh null phenotype has been observed in two independently targeted Blmh null alleles. We cannot rule out the remote possibility that the strategy used to create the Blmh null alleles also disrupted other gene(s), although no other ORF has been detected in the 3.4-kb deleted region (unpub- BLM (100 mg/kg) was delivered (for 7 days) by continuous infusion from a mini-osmotic pump implanted s.c. in the middorsum. TOD, time of death (in days) from pump implantation. 4684 Pharmacology: Schwartz et al. Proc. Natl. Acad. Sci. USA 96 (1999) lished data). Importantly, however, our data suggest that Blmh ablation was both necessary and sufficient for the consequent phenotype.
